| NDC Code | 51285-754-02 |
|---|
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51285-754-02) |
|---|
| Product NDC | 51285-754 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Diamox Sequels |
|---|
| Non-Proprietary Name | Acetazolamide |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20000222 |
|---|
| End Marketing Date | 20190531 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA012945 |
|---|
| Manufacturer | Teva Women's Health, Inc. |
|---|
| Substance Name | ACETAZOLAMIDE |
|---|
| Strength | 500 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [CS] |
|---|